NCT05098522View on ClinicalTrials.gov

Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

March 27, 2023

Study Completion Date

March 27, 2023

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

IRL201104

lyophilised powder for reconstitution for IV dosing

DRUG

Placebo

Matching placebo for IRL201104

Trial Locations (2)

Unknown

Hammersmith Medicines Research, London

King's College London, London

Sponsors
All Listed Sponsors
lead

Revolo Biotherapeutics

INDUSTRY

NCT05098522 - Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter